Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott G Williams

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 23, 2021
Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune DefensesJoseph Sia, Jim Hagekyriakou, Ioana Chindris, et al.
Sleep Advances : a Journal of the Sleep Research Society|May 16, 2023
Diagnosed or prescribed only? A national analysis of initial evaluation and management of insomnia among older adult Medicare beneficiariesEmerson M Wickwire, Sophia L Jobe, Jennifer L Martin, et al.
European Urology Oncology|August 15, 2019
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for <sup>177</sup>Lu-labelled PSMA Radioligand TherapySue Ping Thang, John Violet, Shahneen Sandhu, et al.
Physics and Imaging in Radiation Oncology|March 14, 2022
A statistical, voxelised model of prostate cancer for biologically optimised radiotherapyRobert N Finnegan, Hayley M Reynolds, Martin A Ebert, et al.
BJU International|May 5, 2018
A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocolMichael S Hofman, Declan G Murphy, Scott G Williams, et al.
Neurology|March 28, 2024
Association of Biomarkers of Neuronal Injury and Inflammation With Insomnia Trajectories After Traumatic Brain Injury: A TRACK-TBI StudyJ Kent Werner, Jennifer Albrecht, Vincent F Capaldi, et al.
Sleep & Breathing = Schlaf & Atmung|November 7, 2019
A randomized, placebo-controlled trial using a novel PAP delivery platform to treat patients with OSA and comorbid PTSDAaron Holley, David Shaha, Camille Costan-Toth, et al.
BMC Urology|October 29, 2020
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case reportScott G Williams, Han Xian Aw Yeang, Catherine Mitchell, et al.
BJU International|June 12, 2023
Treatment de-intensification for low-risk biochemical recurrence after radical prostatectomy: rational or risky?Matthew J Roberts, George Hruby, Andrew Kneebone, et al.
Sleep|June 14, 2022
Remote clinical research operations during COVID-19: lessons learned and recommendationsJulianna P Adornetti, Christine E Wade, Maura K Deeley, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|May 23, 2021
Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune DefensesJoseph Sia, Jim Hagekyriakou, Ioana Chindris, et al.
Sleep Advances : a Journal of the Sleep Research Society|May 16, 2023
Diagnosed or prescribed only? A national analysis of initial evaluation and management of insomnia among older adult Medicare beneficiariesEmerson M Wickwire, Sophia L Jobe, Jennifer L Martin, et al.
European Urology Oncology|August 15, 2019
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for <sup>177</sup>Lu-labelled PSMA Radioligand TherapySue Ping Thang, John Violet, Shahneen Sandhu, et al.
Physics and Imaging in Radiation Oncology|March 14, 2022
A statistical, voxelised model of prostate cancer for biologically optimised radiotherapyRobert N Finnegan, Hayley M Reynolds, Martin A Ebert, et al.
BJU International|May 5, 2018
A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocolMichael S Hofman, Declan G Murphy, Scott G Williams, et al.
Neurology|March 28, 2024
Association of Biomarkers of Neuronal Injury and Inflammation With Insomnia Trajectories After Traumatic Brain Injury: A TRACK-TBI StudyJ Kent Werner, Jennifer Albrecht, Vincent F Capaldi, et al.
Sleep & Breathing = Schlaf & Atmung|November 7, 2019
A randomized, placebo-controlled trial using a novel PAP delivery platform to treat patients with OSA and comorbid PTSDAaron Holley, David Shaha, Camille Costan-Toth, et al.
BMC Urology|October 29, 2020
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case reportScott G Williams, Han Xian Aw Yeang, Catherine Mitchell, et al.
BJU International|June 12, 2023
Treatment de-intensification for low-risk biochemical recurrence after radical prostatectomy: rational or risky?Matthew J Roberts, George Hruby, Andrew Kneebone, et al.
Sleep|June 14, 2022
Remote clinical research operations during COVID-19: lessons learned and recommendationsJulianna P Adornetti, Christine E Wade, Maura K Deeley, et al.
Pageof 11